针对肝脏的纳米粒子技术及其在肝脏疾病中的应用
Mengjia Peng1,2,3, Fei Fang1, Bowen Wang1,2,3
1Department of Emergency, The General Hospital of Tibet Military Command, Lhasa, China.
Frontiers in bioengineering and biotechnology
|November 10, 2025
概括
纳米粒子 (NP) 技术为治疗肝脏疾病提供了新的途径. 了解NP如何与肝细胞相互作用是改善向NP传递以更好地诊断和治疗的关键.
科学领域:
- 生物医学工程 生物医学工程
- 肝病学 肝病学是一种肝病学.
- 纳米技术纳米技术
背景情况:
- 肝脏疾病对全球健康造成重大负担.
- 纳米粒子 (NP) 技术为肝脏疾病提供了有前途的治疗途径.
- 肝脏在解毒中的作用及其与循环NP的相互作用使其成为NP介导疗法的首要目标.
研究的目的:
- 审查肝脏侧鼻状腺的生理状况.
- 阐明肝细胞和NP之间的相互作用.
- 为优化针对肝脏的NP输送系统提供基础.
主要方法:
- 文献综述,重点关注NP与肝脏的相互作用.
- 分析肝细胞 (巨细胞,状内皮细胞,肝细胞) 吸收NP机制.
- 在肝脏的鼻状环境中检查NP热带性.
主要成果:
- 在全身注射后,NP主要积聚在肝脏中.
- 肝脏巨细胞,状内皮细胞和肝细胞积极地内化NP.
- 了解NP-肝细胞相互作用对于增强NP在病理部位的积累至关重要.
结论:
- 有针对性的NP传递系统在肝病管理方面具有巨大的潜力.
- 优化NP交付可以改善肝脏疾病的诊断和治疗结果.
- 对NP肝脏生理学的进一步研究将推动NP介导的肝脏疗法.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
113
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
113
Site-Targeted Drug Delivery Systems: Polymeric Carriers
115
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
115


